Submitted by Anonymous (not verified) on 13 August 2025 - 13:57
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 95, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 95, Status: Authorised